Do elevated autoantibodies in patients with multiple sclerosis matter?

Assunta Dal-BiancoFritz WenhodaPaulus Stefan RommerMichael WeberPatrick AltmannJörg KrausFritz LeutmezerSabine Salhofer-Polanyi

Published in: Acta neurologica Scandinavica (2018)

According to our data, elevated serum autoantibodies do not have the potential to serve as a prognostic tool for disease severity in patients with MS Since MS patients with positive serum AABS did not significantly more often suffer from clinical manifest AIs than MS patients with negative serum AABS, the role of routine testing of serum AABS in MS patients should be critically called into question.

Keyphrases

mass spectrometry
multiple sclerosis
ms ms
systemic lupus erythematosus
newly diagnosed
prognostic factors
clinical practice
big data
climate change
patient reported outcomes
deep learning
data analysis